Andrew Spillane is Professor of Surgical Oncology at The University of Sydney, Northern Clinical School. He specialises in the surgical management of breast cancer and melanoma. Andrew is a senior VMO surgeon at the Mater North Sydney, Royal North Shore Hospital and North Shore Private Hospitals. Andrew is past President of Breast Surgeons of Australia and New Zealand Inc. (BreastSurgANZ), a member of the Breast Cancer Trials (formerly ANZBCTG) Scientific Advisory Committee and BCT breast surgery Craft Group Lead, a board member and Deputy Chair of the Board of Melanoma and Skin Cancer (MASC) Trials Group (formerly the ANZMTG). He is a member of the BCNA Medical Advisory Committee and Faculty Member of Melanoma Institute Australia. Andrew is Breast sub-editor for the ANZ Journal of Surgery, a skin malignancy editorial board member of Annals of Surgical Oncology and the Journal of Surgical Oncology and founding co-director of the University of Sydney’s Graduate Certificate in Advanced Breast Surgery. Andrew’s current research interests investigate issues around quality assurance in surgery, safe introduction of new surgical techniques and promoting clinical trial involvement by surgeons. He is involved in clinical and translational research on aspects of breast cancer and melanoma including trial management committee of the MelMART-2 study and active member of the International Neoadjuvant Melanoma Consortium. He has been an author on about 170 peer reviewed publications and co-authored 4 book chapters. He lectures and teaches students at the University of Sydney’s, Northern Clinical School.